Delivery Order SPE2DR25D1017-SPE2DR26F9BGN
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count) with a contract ceiling value of $1,561.85. This firm fixed-price delivery order represents a non-competitive set-aside award and is scheduled for ultimate completion by December 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count units) valued at $3,734.34. This is a firm fixed-price delivery order with an ultimate completion date of December 3, 2025, and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The award was made through open competition with no set-aside designation. AmerisourceBergen, a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count) with a firm fixed price ceiling value of $2,539.62 and ultimate completion date of December 1, 2025. This is a non-set-aside competitive award classified as a delivery order under the company's existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for Carvedilol ER 20 mg capsules (30-count) valued at $10,541.75. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 20 mg capsules (30-count units) on December 8, 2025, with a ceiling value of $1,337.70 and completion date of December 9, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count packages) with a ceiling value of $5,976.74. This is a firm fixed price delivery order with an ultimate completion date of June 20, 2025, and represents a non-set-aside competitive award. The contractor's place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count) valued at $4,399.10 under a firm fixed-price arrangement. This non-set-aside contract represents a single delivery order fulfillment with an ultimate completion date of July 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units) with a ceiling value of $1,267.20 and a firm fixed price structure. The contract is classified as a non-set-aside award, indicating it was competitively procured. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 2, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count units) on January 10, 2025, with a ceiling value of $1,726.39 and an ultimate completion date of January 13, 2025. This firm fixed price delivery order was competitively awarded without any set-aside designation and represents a direct procurement of pharmaceutical products to support federal medical supply needs. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count) with a ceiling value of $1,117.09. This is a firm fixed-price delivery order with an ultimate completion date of June 23, 2025, and represents a competitively awarded, non-set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9BGNDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for Carvedilol Extended Release 20 mg capsules (30-count) with a ceiling value of $2,217.14. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and is scheduled for completion by December 12, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's supply chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive prime contract vehicle enables the company to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs globally. The IDC facilitates flexible procurement of essential medications across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard, with the DLA planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts involving multiple regional awards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 12/10/25 |